Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Shao‑Yan Chen"'
Publikováno v:
Oncology Reports
Long non‑coding RNA (lncRNA) forkhead box P4 antisense RNA 1 (FOXP4‑AS1) has been determined to function as an oncogene in various types of cancer. However, the biological function and the underlying mechanisms of FOXP4‑AS1 in mantle cell lymph
Autor:
Shao-yan Chen, Quan-an Gui
Publikováno v:
DEStech Transactions on Computer Science and Engineering.
By the methods of literature review, experts interview and analogue, the paper analyzed the current situation, features, establishment and development model of equestrian and management in the sports economics and management specialty. Then, several
Autor:
Xuan Lai, Zhen Zhuang, Qian Xie, Shao-Yan Chen, Feng Zhang, Min-Hua Fan, Ning Zhu, Lian He, Ai-Hua Zhang, Tao Wang
Publikováno v:
Archives of Cardiovascular Diseases. 105:211-217
SummaryBackgroundMetabolic syndrome increases the risk of cardiovascular disease (CVD) and all-cause mortality in the general population.AimsTo investigate whether metabolic syndrome affects CVD and all-cause mortality in chronic haemodialysis patien
Publikováno v:
Renal failure. 36(4)
This study aims to quantify and compare the risks of death and end stage renal disease (ESRD) in a prospective cohort of patients with chronic kidney disease (CKD) stages 1-5 under renal management clinic at Peking University Third Hospital and to ev
Autor:
Song Wang, Tao Wang, Chun Yan Su, Wen Tang, Lian He, Ai-Hua Zhang, Hui Zhong, Xin-Hong Lu, Shao-Yan Chen
Publikováno v:
International urology and nephrology. 40(4)
Chronic kidney disease (CKD) has been identified as a growing global burden and traditional health care systems are inadequate for the management of CKD patients. This paper describes an initiative to establish a renal management clinic (RMC) in Chin
Autor:
Xin, Li, Ning-chen, Li, Qiang, Ding, Song-liang, Cai, Hong-xu, Huo, Shao-yan, Chen, Xiao-jian, Gu, Shi-ping, Chen, Yan-qun, Na
Publikováno v:
Zhonghua nan ke xue = National journal of andrology. 12(3)
To study the efficacy and safety of alpha1 adrenoceptor antagonist Naftopidil in the treatment of chronic non-bacterial prostatitis.An opened, self-controlled, multicentral clinical trial was conducted. One hundred and six cases of patients who had b